Quarterly report pursuant to Section 13 or 15(d)

NET LOSS PER SHARE (Tables)

v3.21.2
NET LOSS PER SHARE (Tables)
9 Months Ended
Sep. 30, 2021
NET LOSS PER SHARE  
Schedule of Net Loss Per Share, Basic and Diluted

Three Months Ended September 30, 

Nine Months Ended September 30, 

(in thousands, except per share amounts)

    

2021

    

2020

    

2021

    

2020

Numerator for basic and diluted net loss per share:

  

 

  

  

 

  

Net loss attributable to Common Stockholders

$

(66,879)

$

(19,457)

$

(169,167)

$

(65,027)

Denominator for basic and diluted net loss per share:

 

  

 

  

 

  

 

  

Weighted-average shares

 

260,556

 

159,968

 

251,468

 

158,121

Net loss per share—Basic and Diluted

$

(0.26)

$

(0.12)

$

(0.67)

$

(0.41)

Schedule of antidilutive securities excluded from computation of earnings per share The Company excluded the following potential common shares, presented based on amounts outstanding as of September 30, 2021 and 2020, from the computation of diluted net loss per share attributable to common stockholders because including them would have an anti-dilutive effect (in thousands):

Nine Months Ended September 30, 

2021

    

2020

Common Stock options outstanding

14,500

12,964

Unvested restricted stock units outstanding

8,311

Unvested restricted stock awards outstanding

348

1,317

Common Stock warrants outstanding

619

Total shares

23,159

14,900